Article Details

AstraZeneca's Nirsevimab Approved in the EU - MarketWatch

Retrieved on: 2022-11-04 08:52:47

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Nirsevimab Approved in the EU - MarketWatch. View article details on hiswai:

Excerpt

By Anthony O. Goriainoff AstraZeneca PLC said Friday that nirsevimab, a treatment for the prevention of respiratory syncytial virus, a...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up